Enthorin Therapeutics
Biotechnology Research
The Underlying Biology of Fragile X Syndrome—a Condition Still Lacking Approved Treatments.
2 employees
- Employees
- 2
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Enthorin Therapeutics Overview
- Headquarters
- The Underlying Biology of Fragile X Syndrome—a Condition Still Lacking Approved Treatments.
- Website
- enthorin.com
- Industry
- Biotechnology Research
- Employees
- 2
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Enthorin Therapeutics
Enthorin Therapeutics is a clinical stage pharmaceutical company founded with the goal of developing innovative therapeutics that target brain circuit dysfunction to improve quality of life for patients, families, and communities.
Enthorin Therapeutics Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
- Phone contacts
- 1
- 100.0% coverage
Enthorin Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Michael Yassa | Neuroscientist, Entrepreneur; Writer | Irvine, California, United States |
Email
Phone
|
Compare Similar Companies to Enthorin Therapeutics
Incyte
Pharmaceutical Manufacturing
Alder Hey Children's NHS Foundation Trust
Hospitals And Health Care
Mirum Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Verona Pharma
Biotechnology Research
Longboard Pharmaceuticals
Biotechnology Research
Translucence Biosystems
Biotechnology Research
Augnition Labs
Biotechnology
ClutchKidz LLC
Technology, Information And Internet
Augnition Labs
Biotechnology Research